Lara MIGLIACCIO, project leader in the team "FRONTlab : Frontal systems : functions and dysfunctions" at Paris Brain Institute, explains the causes, symptoms and treatments of Alzheimer's disease.
Comprendre en 2 minutes
News that might interest you
Sometimes, in healthy tissues, mutated cells are seen that may or may not become malignant tumours. This phenomenon has already been described in the endometrium, oesophagus and epidermis. At Paris Brain Institute, Matthieu Peyre and his colleagues
...
03.15.2024
Research, science & health
What if Alzheimer’s disease left its mark on the embryo? Khadijeh Shabani and her colleagues from the “Brain Development” team led by Bassem Hassan (Inserm) at Paris Brain Institute show that the amyloid precursor protein (APP) has a specific
...
06.19.2023
Research, science & health
The diagnosis of atypical forms of Alzheimer's disease is still sometimes difficult. Researchers from Paris Brain Institute have developed an automated algorithm to correlate the specificities of brain lesions with the symptoms associated with these
...
09.18.2022
Research, science & health
Although Alzheimer's disease is not inherited in 95% of cases, nearly 75 genetic susceptibility factors - that is, factors that increase the risk to develop the disease - or protective factors - that decrease the probability to be affected - have
...
07.11.2022
Research, science & health
Although Alzheimer's disease is not hereditary in 99% of cases, genetic factors can increase the risk of developing it. The "Alzheimer's disease, prion diseases" team, co-directed by Marie-Claude Potier (CNRS) at the Paris Brain Institute, has
...
03.24.2022
Research, science & health
What risk factors are associated with Alzheimer's up to 15 years before the onset of the first symptoms? This is a vital question for specialists of this neurodegenerative disease – which develops over many years before becoming clinically visible –
...
02.23.2022
Research, science & health